Prestige Wealth Management Group LLC Immuno Gen, Inc. Transaction History

Prestige Wealth Management Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2024	BUY	$3.67 - $4.92 $1,552 - $2,081	423 New	423 $1,000
Q4 2020 Feb 17, 2021	SELL	$3.7 - $7.66 $1,098 - $2,275	-297 Reduced 41.25%	423 $3,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $1,526 - $4,896	720 New	720 $2,000
Q1 2019 Aug 16, 2019	SELL	$2.41 - $5.91 $1,735 - $4,255	-720 Closed	0 $0
Q4 2018 Apr 16, 2019	BUY	$3.94 - $9.7 $2,836 - $6,983	720 New	720 $3,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.